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Abstract: The information–motivation–behavioral skills (IMB) model has been used to 
explain and promote medication adherence among patients with diabetes and HIV. The objec-
tive of this study was to examine whether the IMB model predicted medication adherence 
among vasculitis patients. Adult vasculitis patients (n=228) completed online questionnaires 
at baseline and 3-month follow-up. Linear regressions were calculated to determine the direct 
effects of information and motivation on medication adherence (P,0.05). A mediation analy-
sis using a bootstrapping approach was used to test whether behavioral skills significantly 
mediated the effect of information and motivation on medication adherence. Participants 
reported high levels of information (M=4.0; standard deviation [SD]=0.68), moderate levels 
of motivation (M=2.7; SD=1.00), and high levels of behavioral skills (M=4.1; SD=0.74). In 
the regression model, only behavioral skills (B=0.38; P,0.001) were significantly associ-
ated with medication adherence; however, mediation analysis revealed that behavioral skills 
significantly mediated the effects of information and motivation on medication adherence. 
The results support the IMB-hypothesized relationships between information, motivation, 
behavioral skills, and medication adherence in our sample. Findings suggest that providers 
should work with vasculitis patients to increase their medication-related skills to improve 
medication adherence.
Keywords: medication adherence, self-efficacy, vasculitis, information, information–motivation–
behavioral skills model
Introduction
Vasculitis is a rare disease that thickens, narrows, and scars the blood vessels.1 It is 
associated with adverse health outcomes such as organ damage1 and higher health care 
costs.2 It has been found that low medication adherence is common among patients 
with vasculitis.3 As vasculitis only affects ~30 per 100,000 individuals in the United 
States,4 few interventions have been designed to promote medication adherence among 
patients with vasculitis. Therefore, a paucity of literature exists to assist public health 
researchers and physicians to increase their knowledge of modifiable behavioral 
skills that could be used to increase medication adherence behaviors among patients 
with vasculitis.5,6
Studies have established that poor vasculitis management, including medication 
adherence, is a predictor of adverse outcomes and lower the patient’s quality of life.7–12 
Management of vasculitis includes adhering to the provider’s recommendations with 
respect to timing, dosage, and frequency of the medication regimen, being motivated 
to adhere to the medication regimen, and applying behavioral skills to adhere to their 
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medication regimen in multiple settings and situations.13,14 
Few studies have applied theoretical frameworks to under-
stand vasculitis self-management behaviors. These studies 
have found that more conflicting medication information 
and less social support from network members (individuals 
who provide emotional, instrumental, informational, and 
appraisal) have been associated with worse medication 
adherence.5,6,15,16 For example, patients who received high 
social support from their providers had higher levels of moti-
vation to adhere to medication regimen resulting in better 
medication adherence.5,13 Additional work has described 
the medication information-seeking behaviors of vasculitis 
patients, but has not examined whether medication informa-
tion seeking is associated with increased behavioral skills 
(self-efficacy) or medication adherence.15
The information–motivation–behavioral skills (IMB) 
model of health behavior change is a theoretical model that 
was developed to predict HIV preventive behavior. How-
ever, the IMB constructs can be applied to multiple health 
promotion behaviors including medication adherence among 
different populations.17 Overall, the results of cross-sectional 
studies from individuals diagnosed with HIV have demon-
strated support for the IMB model in designing interventions 
that improve and predict antiretroviral medication adherence 
among individuals living with HIV.18–22 The IMB model 
has also been applied successfully in assessing medication 
adherence among diabetic patients.14 Therefore, the IMB 
model has proven to be effective in promoting medication 
adherence among other diseases and may be potentially 
successful among patients with vasculitis. Although many 
behavioral-specific theories such as the Health Belief 
Model,23 the Theory of Planned Behavior,24 and the Tran-
stheoretical Model25 posit determinants of behavior that are 
amenable to change, the IMB model is the only model that 
includes adherence-specific information, motivation, and 
behavioral skills as needed for successful adherence among 
patients with vasculitis.
Given that information sources may be more limited 
for patients living with a rare disease, such as vasculitis, 
the IMB model offered a unique framework with which to 
investigate the effects of medication information on patient 
adherence. The IMB model posits that an individual who is 
well informed, motivated, and has the requisite behavioral 
skills (including a high level of self-efficacy) will enact and 
maintain a health promotion behavior such as medication 
adherence.17 According to the IMB model, information 
is defined as adequate knowledge of the medication regi-
men, side effects, drug interactions and adherence, as well 
as heuristics and implicit theories.26 Heuristics are rules 
permitting cognitively effortless behavior regarding adher-
ence, whereas implicit theories are a set of beliefs that require 
cognitive effort to apply adherence decision-making skills.26 
Motivation consists of personal and social attitudes and 
beliefs about medication adherence (I do not like taking my 
vasculitis medicines because they remind me that I have vas-
culitis). Personal motivation is comprised of the individual’s 
attitudes and beliefs, whereas social motivation is comprised 
of social and instrumental support for medication adherence.26 
Lastly, behavioral skills is comprised of objective abilities to 
perform adherence behaviors (the ability to take and properly 
store medications) and self-efficacy (the confidence in the 
ability to perform such adherence behaviors). Thus, medica-
tion adherence is defined as the result of the individual being 
informed about the treatment regimen, motivation to adhere 
to the regimen, and having the behavioral skills (self-efficacy) 
to adhere to the regimen in multiple contexts such as the 
work and home setting. The IMB model specifically posits 
that behavioral skills mediate the effects of information and 
motivation on medication adherence.
The objective of this paper is to examine whether informa-
tion, motivation, and behavioral skills predict medication 
adherence for vasculitis patients. We specifically inves-
tigate whether information and motivation directly affect 
medication adherence or whether they are mediated via 
behavioral skills. Based on the relationships posited in the 
IMB model, we hypothesized that more adherence-related 
information, greater motivation, and higher levels of behav-
ioral skills would be significantly associated with higher 
vasculitis medication adherence among patients. We also 
hypothesized that behavioral skills would significantly 
mediate the positive effects of information and motivation 
on patient medication adherence.
Methods
study design
Data for this analysis come from the Accessing Social 
Support in Symptom Treatment (ASSIST) study, which was 
a longitudinal study that assessed how social support and 
information seeking influenced patient medication adherence 
among patients diagnosed with vasculitis. Data collection 
was from June 2008 to February 2009.6
recruitment
A convenience sample of participants was recruited through 
four methods including distributing study brochures at a 
vasculitis patient conference (n=39), mailing recruitment 
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letters to vasculitis patients who were part of the Glomerular 
Disease Collaborative Network (GDCN) (n=361), contacting 
physician-diagnosed vasculitis patients (n=124), and post-
ing study information on vasculitis websites, and patient 
newsletters, email groups, and support group meetings 
(n=147). Carpenter et al describe these recruitment efforts 
in greater detail.6
sample
Participants completed two online questionnaires admin-
istered 3 months apart. Inclusion criteria included 
1) patients who had a self-reported diagnosis of vasculitis; 
2) were $18 years of age; 3) were able to read and write in 
English; 4) had Internet access; and 5) currently taking at least 
one vasculitis medication. Out of 306 patients, 253 patients 
were eligible for the study. Reasons for ineligibility included 
currently not taking vasculitis medications (n=25), death 
(n=9), lack of access to the Internet (n=9), being too busy 
(n=4), not having vasculitis (n=1), and refusing to participate 
in the study (n=5). A total of 232 patients (91.7%) of the 253 
eligible patients completed the 1-hour baseline questionnaire. 
Yet technical issues (n=7), being too sick (n=4), being too busy 
(n=3), or never responding to study correspondence (n=7) 
were reasons for non-completion. Of the 232 participants who 
completed the baseline survey, only four did not complete 
the 3-month follow-up survey. Three were lost to follow-up 
and one experienced technical difficulties. Thus, resulting in a 
final sample of 228 participants and a 98.2% study completion 
rate. Participants who completed both questionnaires received 
a ten-dollar gift card. Written informed consent was obtained 
from all individual participants included in the study. This 
study was approved by the University of North Carolina at 
Chapel Hill Institutional Review Board.
Measures
The baseline questionnaire assessed sociodemographic char-
acteristics, disease status, and the information measure of the 
IMB model. The 3-month questionnaire assessed vasculitis 
medication adherence, motivation, and behavioral skills 
measures of the IMB model.
sociodemographic and clinical characteristics
Participants answered one item regarding age (in years), 
gender, race/ethnicity (categorized as Non-Hispanic White 
vs other), education (in years), health insurance status 
(insured vs uninsured), disease duration (in years), perceived 
vasculitis severity (1= not at all severe to 10= extremely 
severe), relapse status (currently experiencing a flare vs not), 
and vasculitis type (ie, granulomastosis with polyangiitis, 
microscopic polyangiitis, eosinophilic granulomatosis with 
Polyangiitis, anti-neutrophil cytoplasmic autoantibody, 
Takayasu arteritis, polyarteritis nodosa, Behcet’s disease, 
do not know, and other).
iMB constructs
IMB model constructs were assessed using the validated 
and reliable LifeWindows questionnaire (LW-IMB-AAQ).27 
The IMB questionnaire contains three subscales, including 
information, motivation, and behavioral skills. Because the 
IMB questionnaire had not been used previously with a 
vasculitis patient population, we conducted five cognitive 
interviews with patients to assess the comprehension and 
relevance of the questionnaire items. Cognitive interviews 
are defined as a technique that allows individuals to verbalize 
their opinions and feelings when examining information on a 
specific topic.28 Based on the results of these interviews, one 
item was omitted from the motivation scale because this item 
referred to stigma, which is less of an issue with vasculitis 
patients than HIV patients (Table S1). We also conducted a 
confirmatory factor analysis with three factors and promax 
rotation to assess item loadings. Six items were omitted for 
the following reasons: two informational scale items cross-
loaded with the behavioral skills scale and one information 
scale item did not load on any factor, and two items on 
the behavioral skills scale cross-loaded on the information 
scale (Table 1).
In this study, our final measure included six information 
items, six motivation items, and ten behavioral skills items. 
The information scale included items about possible side 
effects, how to take the medications, and what action to take 
if a dose is missed. Motivation items were reverse-scored so 
that higher motivation scores indicated more positive medi-
cation attitudes and beliefs. Examples of motivation items 
included being frustrated, upset, and worried about taking 
vasculitis medications; higher motivation scores indicated 
more negative medication attitudes and beliefs. Behavioral 
items were reverse-scored so that higher values reflected 
higher levels of behavioral skills (self-efficacy). Behavioral 
items included such items as managing side effects, storing 
medications properly, and refilling medications on time. 
Participants responded to the information and motivation 
items using a 5-item scale including 1= “strongly disagree,” 
2= “somewhat disagree,” 3= “neither,” 4= “somewhat agree,” 
and 5= “strongly agree.” The participants responded to the 
behavioral skills items using a 5-item scale including 1= “very 
easy,” 2= “fairly easy,” 3= “neither,” 4= “fairly hard,” 
Patient Preference and Adherence 2017:11submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
78
Alexander et al
5= “very hard.” Summary subscale scores were created by 
averaging item responses. Higher scores indicated greater 
levels of vasculitis knowledge, vasculitis skills, and moti-
vation (attitudes and beliefs of vasculitis management). 
The Cronbach’s alphas were acceptable to excellent for the 
subscales: information (α=0.70), motivation (α=0.82), and 
behavioral skills (α=0.91).
Vasculitis medication adherence
The Vasculitis Self-Management Survey (VSMS) medica-
tion adherence subscale measured medication adherence.29 
Participants self-reported their medication taking behavior 
during the past 4 weeks. A summary score was created by 
averaging item responses and had a possible range of 0–35. 
The scale was comprised of seven items on a 5-point Likert 
scale. For six items, the scale ranged from 1= “none of the 
time” to 5= “all of the time.” For example, “I skipped a dose 
of my medicine” and “I could have done a better job follow-
ing my health professionals’ recommendations for taking my 
medicine” were items on the medication adherence scale. 
The seventh item (percentage of recommended medications 
taken exactly as directed) ranged from 1= “0%–24%” to 
5= “100%.” In a prior study,29 the subscale had an acceptable 
internal consistency (Cronbach’s α=0.77) and test–retest reli-
ability of 0.60. The Cronbach’s alpha was 0.87 in the current 
study. Higher scores indicated greater adherence.
statistical analyses
Univariate analyses were conducted to characterize the sam-
ple and variables of interest. Pearson correlation (bivariate 
analysis) was used to examine the associations among study 
variables. A linear regression was conducted to examine the 
direct effects of information, motivation, and behavioral 
skills on vasculitis medication adherence. The regression 
controlled for patients’ demographic and clinical characteris-
tics included age, gender, education, race/ethnicity, insurance 
status, self-reported vasculitis type, disease duration, relapse 
status, and perceived vasculitis severity. P-values ,0.05 
were considered to be significant. All analyses were con-
ducted using Statistical Package for Social Sciences software, 
version 22.0.
A bootstrapping approach was used to run a media-
tion model to explore whether behavioral skills mediated 
the effects of information and motivation on medication 
adherence.30,31 The mediation model controlled for age, 
gender, education, race/ethnicity, insurance status, disease 
duration, relapse status, and perceived vasculitis severity. 
Multiple reasons are presented below as to why bootstrapping 
was conducted rather than causal steps to test for mediation. 
First, bootstrapping is a nonparametric test that does not 
impose the constraint of multivariate normality; therefore, 
it is robust for situations where data are skewed. Vascu-
litis patients are relatively adherent;29 thus, the mediation 
approach that we used is less affected by skewness offering 
advantages. Second, bootstrapping calculates an overall 
point estimate and confidence interval for each mediated 
(indirect) effect by generating a sampling distribution from 
5,000 samples (with replacement) from the full data set 
reducing type I error rates.31 Third, bootstrapping produces 
contrasts to test the relative strength of each mediated effect; 
Table 1 sample characteristics (n=228)
Characteristics Mean ± SD 
or n (%)
Range
Sociodemographics
Age, years 51.0±13.3 21.0–82.0
gender
Male 69 (30.3)
Female 159 (69.7)
race/ethnicity
non-hispanic White 208 (91.2)
Other 20 (8.8)
Years of education 15.6±2.8 4.0–22.0
health insurance
insured 211 (93.4)
Uninsured 15 (6.6)
Clinical
Years with vasculitis 6.4±6.2 0.5–36.5
Perceived vasculitis severitya 4.5±2.3 1.0–10.0
relapse status
currently relapsing 64 (28.4)
not currently relapsing 161 (71.6)
Self-reported vasculitis type
granulomatosis with polyangiitis (formerly 
Wegener’s granulomatosis)
136 (59.6)
Microscopic polyangiitis 18 (7.9)
eosinophilic granulomatosis with polyangiitis 
(formerly churg–strauss syndrome)
29 (12.7)
Anti-neutrophil cytoplasmic autoantibody 
disease
5 (2.2)
Takayasu arteritis 11 (4.8)
Polyarteritis nodosa 10 (4.4)
Behcet’s disease 4 (1.8)
Do not know 2 (0.9)
Other 14 (6.1)
Vasculitis medication adherenceb 4.3±0.69 1.6–5.0
informationc 4.0±0.68 1.5–5.0
Motivationd 2.7±1.00 1.0–5.0
Behavioral skillse 4.1±0.74 2.0–5.0
Notes: aPerceived severity ranged from “not at all severe” to “extremely severe.” 
bPossible score range =1–5, higher scores indicate greater adherence. cPossible 
score range =1–5, higher scores indicate more vasculitis knowledge. dPossible score 
range =1–5, higher scores indicate higher motivation. ePossible score range =2–5, 
higher scores indicate higher levels of behavioral skills.
Abbreviation: sD, standard deviation.
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yet, multiple mediators cannot be contrasted using a conven-
tional causal steps approach.32 Finally, bootstrapping with 
bias-corrected confidence intervals has more power (exceeds 
0.80 for samples of 250) to detect significant specific indirect 
effects.33 Bias-corrected 95% confidence intervals were used 
to determine whether the point estimates for each indirect 
effect were significant; confidence intervals that contained 
zero were considered non-significant. Participants with miss-
ing data were omitted from the analysis.
All procedures followed were in accordance with the 
ethical standards of the responsible committee on human 
experimentation (institutional and national) and with the 
Helsinki Declaration of 1975, as revised in 2000.
Results
Univariate analyses
A total of 228 individuals with vasculitis participated in the 
study (Table 1). Overall, participants reported high levels 
of information (M=4.0; SD=0.68), moderate levels of moti-
vation (M=2.7; SD=1.00), high levels of behavioral skills 
(M=4.1; SD=0.74), and high levels of medication adherence 
(M=4.3; SD=0.69).
Bivariate analyses
Table 2 presents the bivariate associations among study vari-
ables. Better vasculitis medication adherence was associated 
with more adherence-related information (r=0.23, P,0.01), 
higher motivation scores (r=0.33, P,0.01), more behavioral 
skills (r=−0.48, P,0.01), older age (r=0.23, P,0.01), and 
female gender (r=−0.16, P,0.05).
Greater behavioral skills were associated with 
more adherence-related information (r=0.43, P.0.01), 
higher motivation scores (r=0.43, P.0.01), older age 
(r=0.21, P.0.01), lower perceived vasculitis severity 
(r=−0.20, P.0.01), currently–relapsing vasculitis status 
(r=0.18, P.0.01), and female gender (r=−0.16, P.0.05).
regression analyses
Table 3 presents linear regression results that examined the 
direct effects of information, motivation, and behavioral 
skills on medication adherence (adjusted R2=0.25). Only 
behavioral skills (B=0.38; P,0.001) were significantly 
associated with patient medication adherence; high levels of 
behavioral skills were related to high levels of medication 
adherence. The beta value of 0.38 indicates that a change of 
one standard deviation in the predictor variable (behavioral 
skills) would result in a change of 0.38 standard deviations 
in vasculitis medication adherence. None of the covariates 
were significantly related to medication adherence including 
attitudes and beliefs (motivation). A mediation analysis was 
then conducted to assess whether the non-significant effects 
of information and motivation were mediated by behavioral 
skills. Preacher and Hayes suggest that there are some cir-
cumstances in which an indirect mediation effect can occur 
without the presence of a significant direct effect.30,31
Mediation analysis
Table 4 presents the summary of the mediation analysis for 
the direct and indirect effect of information and motivation on 
medication adherence with behavioral skills as the mediating 
variable. As shown in Figure 1, an examination of indirect 
effects revealed that motivation and information were posi-
tively related to behavioral skills, and behavioral skills were 
significantly associated with higher medication adherence.
Table 2 correlations of all study variables
Variables Correlations
1 2 3 4 5 6 7 8 9 10 11 12
information – 0.290** 0.277** 0.398** 0.106 −0.163* 0.050 0.075 0.013 −0.041 0.060 0.075
Motivation – 0.327** 0.430** 0.298* −0.212* 0.074 −0.236** 0.084 0.261** −0.086 0.131*
Vasculitis medication adherence – 0.484** 0.226** −0.164* 0.011 −0.122 0.012 0.066 0.017 0.058
Behavioral skills – 0.214** −0.157* 0.009 −0.196** 0.029 0.176** −0.012 0.071
Age – −0.192** −0.057 −0.081 0.046 0.098 −0.009 0.106
gendera – −0.050 0.113 −0.103 −0.072 0.187** −0.175**
education – −0.179** 0.040 0.170* −0.103 0.178**
Perceived vasculitis severity – −0.080 −0.440** 0.208** −0.129
race/ethnicitya – 0.045 −0.140* 0.103
relapse statusa – −0.217** 0.121
Vasculitis type – −0.187**
Disease duration –
Notes: *Correlation is significant at 0.05 level (2-tailed). **Correlation is significant at 0.01 level (2-tailed). aAll dichotomous variables (male, currently relapsing, and other 
race) indicate 1.
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Discussion
We examined whether the IMB model could be applied to 
explain medication adherence among patients living with a 
rare chronic disease. The authors hypothesized that higher 
levels of information, motivation, and behavioral skills 
would be significantly associated with higher vasculitis 
medication adherence among patients and that the effects of 
information and motivation on adherence would be mediated 
by increased behavioral skills. After conducting a media-
tion analysis, we found support for the IMB-hypothesized 
relationships between information, motivation, behavioral 
skills, and medication adherence in our sample. Moreover, 
we found, as predicted by the IMB model, that behavioral 
skills mediated the effects of information and motivation on 
medication adherence.
Results revealed that behavioral skills significantly 
mediated the effects of information and motivation on 
medication adherence. These findings are similar with pre-
vious studies, which have also found that behavioral skills 
were associated with higher medication adherence among 
patients with an infectious disease16,17,19,20 and that behavioral 
skills mediated the effects of information and motivation on 
medication adherence.34,35 Although the IMB was developed 
to explain medication adherence in HIV patients, it is also 
applicable for patients living with a chronic rare disease such 
as vasculitis. Thus, our findings were comparable to other 
studies in that more positive motivation scores indicated 
higher behavioral skills.
Although these findings highlight the importance of the 
IMB model for promoting medication adherence, additional 
research is needed to explain what types of information are 
important to vasculitis patients. Additionally, qualitative 
studies are warranted to examine how to best address 
patients’ attitudes toward their medications in order to 
increase their motivation. Information and motivation are 
both key components for vasculitis patients’ medication 
adherence because they increase behavioral skills including 
self-efficacy. If vasculitis patients are experiencing medica-
tion adherence issues then health care providers may want to 
directly address these issues by providing credible adherence-
related information and verify that patients have the skills 
necessary to properly adhere, including having accurate 
knowledge of how to take medications and incorporate 
Table 3 Unstandardized beta (B) coefficients and P-values for 
linear regression predicting vasculitis medication adherence
Variables Vasculitis medication 
adherencea (n=227)
Adjusted R2
B (SE) P-values
information 0.07 (0.07) 0.30 0.25
Motivation 0.09 (0.05) 0.07
Behavioral skills 0.38 (0.07) ,0.01
Age 0.00 (0.00) 0.32
gender −0.10 (0.10) 0.29
education −0.01 (0.02) 0.67
race/ethnicity −0.00 (0.16) 0.99
Vasculitis type 0.02 (0.02) 0.42
Disease duration −0.01 (0.01) 0.46
relapse status −0.08 (0.12) 0.45
Perceived vasculitis severity −0.02 (0.02) 0.41
Notes: aOne participant was excluded from the regression due to missing data. 
Bold value represents a statistically significant result.
Abbreviation: se, standard error.
Table 4 summary of mediation results for the direct and indirect effect of information and motivation on medication adherence with 
behavioral skills as the mediating variable (n=208)a
Variables Estimate (SE) P-value
Independent variables to mediating variables
Motivation → behavioral skills 0.1757 (0.0501) 0.0006
information → behavioral skills 0.3227 (0.0672) ,0.0001
Mediating variables to dependent variable (direct effects)
Behavioral → medication adherence 0.3802 (0.0685) ,0.0001
Total effect of independent variables on dependent variable
Motivation → medication adherence 0.1587 (0.0518) 0.0025
information → medication adherence 0.1972 (0.0695) 0.0050
Independent variables on dependent variable (direct effects)
Motivation → medication adherence 0.0919 (0.0497) 0.0660
information → medication adherence 0.0745 (0.0685) 0.2781
Independent variables to dependent variables (indirect effects) Bias-corrected 95% 
confidence intervals
Motivation → medication adherence 0.0678 (0.0257) 0.0288–0.1326
information → medication adherence 0.1245 (0.0455) 0.0511–0.2315
Note: aAge, race/ethnicity, gender, education, relapse status, perceived vasculitis severity, and disease duration were controlled for in this model.
Abbreviation: se, standard error.
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medication-taking in their daily schedules. By implementing 
these recommendations, providers could potentially improve 
patient’s behavioral skills.
Limitations
Findings should be interpreted in light of the study’s 
limitations. First motivation, behavioral skills, and medica-
tion adherence were all measured at the 3-month data collec-
tion time point, which limits our ability to truly test whether 
mediation occurred. However, our results are consistent 
with the IMB model and previous studies. Second, the study 
sample is a convenience sample which is not representative of 
the larger vasculitis population; thereby, limiting generaliz-
ability. Future research should attempt to recruit a diverse 
sample (ie, race/ethnicity, gender, and education). Third, 
selection bias is present in the study because patient’s self-
reported medication adherence (ie, relatively high adherence 
with low variance). Fourth, the information, motivation, 
and behavioral skills measures were limited because of 
the removal of items, although all measures had an acceptable 
Cronbach alpha. The authors removed certain items from the 
LW-IMB-AAQ questionnaire because those items were not 
relevant to patients with vasculitis or performed poorly on 
factor analysis. Lastly, this sample does not demonstrate the 
direct effects of information and motivation on medication 
adherence that have been seen in previous research among 
patients living with HIV. The results of the regression analy-
sis indicated that only behavioral skills were a significant 
predictor of medication adherence.
Practical implications
Poor medication adherence among vasculitis patients 
can result in morbidity, mortality, and high health care 
expenses. Providers and public health professionals are 
in an essential position to increase vasculitis patients’ 
information, motivation, and behavioral skills when taking 
their medications. Our findings indicate that patients with 
higher levels of behavioral skills have better medication 
adherence. For this reason, providers may want to increase 
awareness of adverse events of medication non-adherence 
among vasculitis patients and propose practical strategies 
for increasing medication adherence. For example, physi-
cians could possibly teach patients how to incorporate their 
medication into their daily schedule, assist the patient in 
finding an accessible pharmacy within close proximity of 
their home environment, or having the patient repeat the 
medication directions and proper storage of the medication 
during the office visit, which are all specific behavioral skills 
that could lead to better medication adherence.36,37 Also, our 
findings demonstrate that positive attitudes and beliefs were 
related to better medication adherence among our sample. 
It may be helpful to the patient if the provider asked about 
the patient’s personal and cultural beliefs when prescribing 
medications. This will not only help to assess the patients’ 
views of their medications but also help to build a trusting 
relationship among patients and health care providers. In 
addition, patients with negative attitudes and beliefs may 
benefit from a support group38,39 to increase social support 
among vasculitis patients who may possibly feel alienated 
from family members and friends.
Conclusion
In conclusion, we found support for the applicability of the 
IMB model in explaining medication adherence for vasculitis 
patients. IMB model-based efforts could include strategies 
for health care providers to assist patients in increasing their 
information, motivation, and behavioral skills to promote 
medication adherence. Future studies should evaluate these 
efforts to demonstrate improvement in self-care behaviors 
including information quality to promote medication adher-
ence among patients with vasculitis.
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Table S1 rotated factor loadings of iMB items: 3-factor solution
IMB 
constructs
Survey items Factor loadings
Factor 1 Factor 2 Factor 3
information i know what the possible side effects of each of my vasculitis medicines are −0.032 0.006 0.736
I understand how each of my vasculitis medicines works in my body to fight vasculitis 0.005 0.003 0.721
i know how each of my vasculitis medicines is supposed to be taken −0.019 0.129 0.692
i know what to do if i miss a dose of my vasculitis medicines −0.062 0.087 0.645
i believe that if i take my vasculitis medicines as prescribed, i will live longer 0.032 0.020 0.491
if i do not take my vasculitis medicines as prescribed, these kinds of medicines may not 
work for me in the future
0.039 −0.074 0.356
As long as i am feeling healthy, missing my vasculitis medicines from time to time is OKa 0.369 −0.187 0.247
skipping a few of my vasculitis medicines from time to time would not really hurt my 
healtha
0.432 −0.237 0.173
i believe that my vasculitis medications do not interact with alcohola 0.048 0.253 −0.378
Motivation it upsets me that the vasculitis medicines i have been prescribed can cause side effects −0.120 0.834 −0.027
it upsets me that the vasculitis medicines i have been prescribed can affect the way i look −0.059 0.810 −0.057
i am worried that the vasculitis medicines i have been prescribed will hurt my health −0.109 0.776 0.076
it frustrates me to think that i will have to take these medicines for the rest of my life 0.012 0.665 0.013
i get frustrated taking my vasculitis medicines because i have to plan my life around them 0.129 0.607 −0.024
i do not like taking my vasculitis medicines because they remind me that i have vasculitis 0.137 0.533 0.022
i am worried that other people might realize that i have a disease if they see me taking my 
vasculitis medicinesa
0.166 0.247 −0.002
Behavioral how hard or easy is it for you to take vasculitis medicines when you do not feel good 
emotionally?
0.872 0.112 −0.104
how hard or easy is it for you to make vasculitis medicines part of your daily life? 0.867 −0.002 −0.038
how hard or easy is it for you to take your vasculitis medicines when you are wrapped up 
in what you are doing?
0.827 −0.083 −0.022
how hard or easy is it for you to remember to take your vasculitis medicines? 0.802 −0.079 0.023
how hard or easy is it for you to take your vasculitis medicines when your usual routine 
changes?
0.788 −0.006 0.001
how hard or easy is it for you to take your vasculitis medicines when you do not feel 
good physically?
0.773 0.110 −0.198
how hard or easy is it for you to take your vasculitis medicines when you feel good 
physically?
0.757 0.012 0.007
how hard or easy is it for you to manage the side effects of your vasculitis medicines? 0.658 0.087 −0.087
how hard or easy is it for you to talk to your health care provider about your vasculitis 
medicines?
0.481 0.204 0.078
How hard or easy is it for you to get your vasculitis medicines refilled on time? 0.552 −0.066 0.153
how hard or easy is it for you to stay informed about your vasculitis treatment?a 0.394 0.105 0.339
how hard or easy is it for you to get the support you need from others for taking your 
vasculitis medicines?a
0.295 0.162 0.308
Notes: “There are times when it is hard for me to take my vasculitis medications when i drink alcohol or use street drugs” was omitted from the behavioral scale based on 
cognitive interviews with vasculitis patients. “how hard or easy is it for you to take your vasculitis medications because the pills are hard to swallow, taste bad, or make you 
sick to your stomach” was omitted from the behavioral scale based on cognitive interviews with vasculitis patients. Possible score range =1–5, higher scores indicate greater 
adherence. aitems that were omitted for poor loadings or cross loadings in red.
Abbreviation: iMB, information–motivation–behavioral skills.
